Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

933 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICE.
Bach M, Bauersachs R. Bach M, et al. Thromb Haemost. 2016 Sep 28;116(Suppl. 2):S24-S32. doi: 10.1160/TH16-06-0486. Epub 2016 Sep 14. Thromb Haemost. 2016. PMID: 27623682
COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study.
Cohen AT, Maraveyas A, Beyer-Westendorf J, Lee AYY, Mantovani LG, Bach M; COSIMO Investigators. Cohen AT, et al. Among authors: bach m. Thromb J. 2018 Sep 4;16:21. doi: 10.1186/s12959-018-0176-2. eCollection 2018. Thromb J. 2018. PMID: 30186045 Free PMC article.
Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study.
Amarenco P, Haas S, Hess S, Kirchhof P, Lambelet M, Bach M, Turpie AGG, Camm AJ. Amarenco P, et al. Among authors: bach m. Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):70-79. doi: 10.1093/ehjcvp/pvy041. Eur Heart J Cardiovasc Pharmacother. 2019. PMID: 30423165
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS.
Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Lambelet M, Bach M, Turpie AGG. Camm AJ, et al. Among authors: bach m. Europace. 2019 Mar 1;21(3):421-427. doi: 10.1093/europace/euy160. Europace. 2019. PMID: 30052894
Global Prospective Safety Analysis of Rivaroxaban.
Kirchhof P, Radaideh G, Kim YH, Lanas F, Haas S, Amarenco P, Turpie AGG, Bach M, Lambelet M, Hess S, Camm AJ; Global XANTUS program Investigators. Kirchhof P, et al. Among authors: bach m. J Am Coll Cardiol. 2018 Jul 10;72(2):141-153. doi: 10.1016/j.jacc.2018.04.058. J Am Coll Cardiol. 2018. PMID: 29976287
Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
Kirchhof P, Bach M, Camm AJ. Kirchhof P, et al. Among authors: bach m. J Am Coll Cardiol. 2018 Nov 13;72(20):2546-2547. doi: 10.1016/j.jacc.2018.09.024. J Am Coll Cardiol. 2018. PMID: 30442303 No abstract available.
Evaluation of a heparin assay method using a fluorogenic synthetic peptide substrate for thrombin.
Choo IH, Didisheim P, Doerge ML, Johnson ML, Bach ML, Melchert LM, Johnson WJ, Taylor WF. Choo IH, et al. Among authors: bach ml. Thromb Res. 1982 Jan 1-15;25(1-2):115-23. doi: 10.1016/0049-3848(82)90220-1. Thromb Res. 1982. PMID: 7064128
Clinical evaluation of a new test of hemostasis: the Filter Bleeding Time.
Uchiyama S, Bach ML, Didisheim P, Bowie EJ. Uchiyama S, et al. Among authors: bach ml. Thromb Res. 1984 Jun 1;34(5):397-405. doi: 10.1016/0049-3848(84)90244-5. Thromb Res. 1984. PMID: 6740568
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
Cohen M, Adams PC, Hawkins L, Bach M, Fuster V. Cohen M, et al. Among authors: bach m. Am J Cardiol. 1990 Dec 1;66(19):1287-92. doi: 10.1016/0002-9149(90)91155-y. Am J Cardiol. 1990. PMID: 2244556 Clinical Trial.
Estimation of pulmonary arterial wedge pressure by pulsed Doppler echocardiography and phonocardiography.
Berger M, Bach M, Hecht SR, Van Tosh A. Berger M, et al. Among authors: bach m. Am J Cardiol. 1992 Feb 15;69(5):562-4. doi: 10.1016/0002-9149(92)91007-q. Am J Cardiol. 1992. PMID: 1736626 No abstract available.
933 results
Jump to page
Feedback